FDA Approval The latest news regarding FDA applications, processes, and approval. This section contains releases regarding the Food and Drug Administration’s consideration of new products, drugs, therapies and treatments. Find announcements covering every stage of the FDA application process, from filing to eventual approval, including appeals, resubmissions, and safety alerts.

Dec 16, 2014

08:00 ET

Dec 16, 2014

04:49 ET

ScheBo M2-PK Quick(TM) Stool Test for Colorectal Cancer Screening

Dec 16, 2014

04:00 ET

Dec 16, 2014

01:26 ET

ScheBo M2-PK Quick(TM) Stool Test for Colorectal Cancer Screening

Dec 16, 2014

01:22 ET

Dec 15, 2014

17:02 ET

Dec 15, 2014

14:00 ET

ScheBo M2-PK Quick(TM) Stool Test for Colorectal Cancer Screening

Dec 15, 2014

10:30 ET

FDA clearance: NBI has visualized Non-Muscle-Invasive Bladder Cancer (NMIBC) lesions in an additional 17 percent of patients, as compared to white light. Blue and green light are strongly absorbed by hemoglobin (blood) and appear darker than normal tissue.

Dec 15, 2014

09:48 ET

Dec 15, 2014

09:01 ET

Dec 12, 2014

08:00 ET

Dec 12, 2014

04:22 ET

Dec 11, 2014

15:17 ET

Dec 11, 2014

10:15 ET

Dec 11, 2014

07:52 ET

Dec 11, 2014

07:30 ET

Dec 11, 2014

07:00 ET

Dec 11, 2014

07:00 ET

ArmaGen aims to transform the treatment of severe neurological disorders by engineering and developing revolutionary therapies for the brain.

Dec 10, 2014

15:34 ET

Dec 10, 2014

09:00 ET

Dr. Carlos M. Ferrario, professor of surgery and founder of the Hypertension and Vascular Research Center at Wake Forest Baptist Medical Center. (Credit: Cameron Dennis / Wake Forest Baptist HealthWire)

Jump to news releases